Use of antifungal agents has increased over past few decades. A number of risk factors such as immunosuppression, broad spectrum antibiotics, dialysis, pancreatitis, surgery, etc., have been linked with the increased risk of invasive candidiasis. Though there are various guidelines available for the use of antifungal therapy, local/regional epidemiology plays an important role in determining the appropriate choice of agent in situations where the offending organism is not known (i.e. empirical, prophylactic or preemptive therapy). Developing countries like India need to generate their own epidemiological data to facilitate appropriate use of antifungal therapy. In this article, the authors have highlighted the need for region-specific policies/guidelines for treatment of invasive candidiasis. Currently available Indian literature on candidemia epidemiology has also been summarized here.
Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998;27:781-88.
Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida blood stream infection until positive blood culture results are obtained: A potential risk factor of hospital mortality. Antimicrob Agents Chemother 2005;49:3640-5.
Clancy CJ, Nguyen M H. Finding the "Missing 50%" of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care. Clin Infect Dis 2013;56:1284-92.
Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D. Risk factors for invasive fungal disease in critically ill adult patients: A systematic review. Crit Care 2011;15.
Ahmadi A, Ardehali SH, Beigmohammadi MT, Hajiabdolbaghi M, Hashemian SM, Kouchek M et al. Invasive candidiasis in intensive care unit; consensus statement from an Iranian panel of experts, July 2013. JRSM Open 2014;26:5.
Harrison D, Muskett H, Harvey S, Grieve R, Shahin J, Patel K, et al. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: The Fungal Infection Risk Evaluation (FIRE) Study. Health Technol Assess 2013;17:1-156.
Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE, et al. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-535.
Bow EJ, Evans G, Fuller J, Laverdière M, Rotstein C, Rennie R, et al. Canadian clinical practice guidelines for invasive candidiasis in adults. The Canadian Journal of Infectious Diseases and Medical Microbiology 2010;21:122-150.
Limper AH, Knox KS, Sarosi GA, Ampel NM, Bennett JE, Catanzaro A, et al. An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients. Am J Respir Crit Care Med 2011;183:96-128.
Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: Non-neutropenic adult patients. Clin Microbiol Infect 2012;18 Suppl 7:19-37.
Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J Clin Microbiol 2011;49:396-9.
Montagna MT, Lovero G, Borghi E, Amato G, Andreoni S, Campion L et al. Candidemia in intensive care unit: A nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013. Eur Rev Med Pharmacol Science 2014;18:661-74.
Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection 2007;35:256-9.
Singh RI, Xess I, Mathur P, Behera B, Gupta B, Misra MC. Epidemiology of candidaemia in critically ill trauma patients: Experiences of a level I trauma centre in North India. J Med Microbiol 2011;60:342-8.
Chander J, Singla N, Sidhu SK, Gombar S. Epidemiology of Candida blood stream infections: Experience of a tertiary care centre in North India. J Infect Dev Ctries 2013;16;7:670-5.
Singhi S, Rao DS, Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 2008;9:91-5.
Baradkar VP, Mathur M, Kumar S, Rathi M. Candida glabrata emerging pathogen in neonatal sepsis. Ann Trop Med Pub Health 2008;1:5-8.
Saha R, Das Das S, Kumar A, Kaur IR. Pattern of Candida isolates in hospitalized children. Indian J Pediatr 2008;75:858-60.
Goel N, Ranjan PK, Aggarwal R, Chaudhary U, Sanjeev N. Emergence of non albicans Candida in neonatal septicemia and antifungal susceptibility: Experience from a tertiary care center. J Lab Physicians 2009;1:53-5.
Kothari A, Sagar V. Epidemiology of Candida blood stream infections in a tertiary care institute in India. Indian J Med Microbiol 2009;27:171-172.
Adhikary R, Joshi S. Species distribution and anti-fungal susceptibility of Candidaemia at a multi super-specialty center in Southern India. Indian J Med Microbiol 20011;29:309-11.
Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res 2012; 136:997-1003.
Sardana V, Pandey A, Madan M, Goel SP, Asthana AK. Neonatal candidemia: A changing trend. Indian J Pathol Microbiol 2012;55:132-3.
Juyal D, Sharma M, Pal S, Rathaur VK, Sharma N. Emergence of non-albicans Candida species in neonatal candidemia. N Am J Med Sci 2013;5:541-5.
Giri S, Kindo AJ, Kalyani J. Candidemia in intensive care unit patients: A one year study from a tertiary care center in South India. J Postgrad Med 2013;59:190-5.
Kaur R, Goyal R, Dhakad MS, Bhalla P, Kumar R. Epidemiology and Virulence Determinants including Biofilm Profile of Candida Infections in an ICU in a Tertiary Hospital in India. Journal of Mycology 2014;2014:1.
Pahwa N, Kumar R, Nirkhiwale S, Bandi A. Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Indian J Med Microbiol 2014;32:44-8.
Iriart X, Lavergne RA, Fillaux J, Valentin A, Magnaval JF, Berry A, et al. Routine identification of medical fungi by the new Vitek MS matrix-assisted laser desorption ionization-time of flight system with a new time-effective strategy. J Clin Microbiol 2012;50:2107-10.
Castanheira M, Woosley LN, Diekema DJ, Jones RN, Pfaller MA. Candida guilliermondii and other species of candida misidentified as Candida famata: Assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs. J Clin Microbiol 2013;51:117-24.
Rodrigues CF, Silva S, Henriques M. Candida glabrata: A review of its features and resistance. Eur J Clin Microbiol Infect Dis 2014;33:673-88.
Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, An Emerging Fungal Pathogen. Clin Microbiol Rev. 2008;21:606-25.
Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: A persistent public health problem. Clin Microbiol Rev 2007;20:133-63.
Cantón E, Pemán J, Hervás D, Espinel-Ingroff A. Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods. J Antimicrob Chemother. 2013;68:864-8.
Chalmers CM, Bal AM. Management of fungal infections in the intensive care unit: A survey of UK practice. Br. J. Anaesth 2011;106:827-31.
Swoboda S, Lichtenstern C, Ober MC, Taylor LA, Störzinger D, Michel A, et al. Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs. Chemotherapy 2009;55:418-24.